Stocklytics Platform
Asset logo for symbol ZTS
Zoetis
ZTS68
$179.91arrow_drop_down0.47%-$0.84
S&P500
Asset logo for symbol ZTS
ZTS68

$179.91

arrow_drop_down0.47%

Performance History

Chart placeholder
Key Stats
Open$182.25
Prev. Close$180.75
EPS5.19
Next Earnings DateDec 5, 2024
LOWHIGH
Day Range179.25
183.85
52 Week Range144.80
201.92
Ratios
EPS5.19

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Correlated Companies

Price$805.15
Perf. (24h)
arrow_drop_down1.95%-$16.03
Market Cap$738.87B
Price$570.00
Perf. (24h)
arrow_drop_up1.84%$10.32
Market Cap$527.83B
Price$160.66
Perf. (24h)
arrow_drop_up0.63%$1.02
Market Cap$382.01B
Price$185.19
Perf. (24h)
arrow_drop_up1.65%$3.02
Market Cap$326.96B

About Zoetis (ZTS)

Zoetis Inc (ZTS) is a global leader in the discovery, development, manufacture, and commercialization of animal health medicines and vaccines. With a rich history in the animal health industry, Zoetis has established itself as a trusted name in providing innovative solutions to improve the health and well-being of animals worldwide. The company's portfolio includes a wide range of products for livestock, poultry, and companion animals, addressing a diverse set of medical needs.
Zoetis Inc (ZTS) has a strong market presence, with a market capitalization of over $70 billion. This underscores the company's position as a key player in the animal health sector. The company's stock price history reflects its consistent growth and performance over the years, demonstrating its ability to generate value for investors. ZTS stock has shown resilience even in challenging market conditions, which speaks to the strength of the company's business model and its ability to adapt to changing dynamics.
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
CEO
Ms. Kristin C. Peck
Headquarters
Parsippany
Employees
13800
Exchange
NYSE
add Zoetis  to watchlist

Keep an eye on Zoetis

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is Zoetis 's (ZTS) price per share?
The current price per share for Zoetis (ZTS) is $179.91. The stock has seen a price change of -$0.85 recently, indicating a -0.47% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for Zoetis (ZTS)?
For Zoetis (ZTS), the 52-week high is $201.92, which is 12.23% from the current price. The 52-week low is $144.8, the current price is 24.25% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is Zoetis (ZTS) a growth stock?
Zoetis (ZTS) has shown an average price growth of 0.41% over the past three years. It has received a score of 48 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Zoetis as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is Zoetis (ZTS) stock price performance year to date (YTD)?
As of the latest data, Zoetis (ZTS) has a year-to-date price change of -8.48%. Over the past month, the stock has experienced a price change of 5.27%. Over the last three months, the change has been 13.57%. Over the past six months, the figure is -6.06%. Looking at a longer horizon, the five-year price change stands at 56.29%.
help
Is Zoetis (ZTS) a profitable company?
Zoetis (ZTS) has a net income of $2.34B, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 68.28% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 36.58% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $8.54B, with a revenue growth rate of 5.74%, providing insight into the company's sales performance and growth. The gross profit is $5.83B. Operating income is noted at $3.07B. Furthermore, the EBITDA is $3.74B.
help
What is the market capitalization of Zoetis (ZTS)?
Zoetis (ZTS) has a market capitalization of $82.06B. The average daily trading volume is 1.97M, indicating the stock's liquidity and investor engagement.

News

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level